quadraScope Venture Fund — Full Portfolio
13 tracked investments · listed companies and verified rows first
HealthtechMiami, US
Agustin Fernandez Santana III(Executive Officer, Director)Jeffrey B. Madden(Executive Officer, Director)inDavid Buchsbaum(Executive Officer)Frank Mattner(Director)
BoardWalter Schmidt(Director)
Alden Scientific is a biotech company with over 40 scientists, bioinformaticians, engineers, clinicians, and researchers developing immunological research capabilities.
AI & Machine LearningBiotechDigital HealthCambridge, US
James Heywood(CEO & Founder)
Co-investorsiSelect FundService Provider CapitalDeep Future
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesMissouri Technology Corporation
Cosmica builds OrganAge™, a blood-based biomarker tool that scores biological aging across nine physiological systems, and an intervention engine that ranks foods, supplements, and activities by how they act on a person's aging-related genes.
BiotechDigital HealthLongevity
David Furman(Founder & Chief Executive Officer)Abhay Saini(Co-founder & Chief Operating Officer)inFei Wu(Chief Scientific Officer)
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalAxial VC+1 more
A clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research.
Digital HealthHealthtechLongevityWellness & FitnessMiami, US
Petr Sramek(Co-founder & Managing Partner)
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)Hans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSRemiges Ventures, Inc.
Co-investorsLauder PartnersMelnichek Investments
Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.
BiotechHealthtechMedical DevicesSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
Co-investorsThynk Capital
Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease.
AI & Machine LearningBiotechDeep TechLongevity
Co-investorsBeiersdorf Innovation FundBeresford VenturesDraper AssociatesPortal Innovations
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.